Home Biolexis

Biolexis

In operation
-
Biotechnology, Vaccine Developer
Basic
Enterprise Profile

Basic Information

Biolexis is an emerging biotechnology and vaccine company with the capability to develop and commercialize products for the global market. The company, a wholly-owned subsidiary of Stelis, focuses on building and licensing a portfolio of advanced biosimilars, peptides, and vaccines.
Biolexis Private Limited
Bangalore,Karnataka,India
unclear
--
--
cs@stelis.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Biotechnology
Concept
Disease Prevention
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention)